Who are Geron Corporation's main suppliers?

Geron Corporation (GERN) key suppliers include: BIOPHARMA-CREDIT-INVESTMENTS-V-MASTER-LP, BIOPHARMA-CREDIT-PLC, BPCR-LIMITED-PARTNERSHIP, JANSSEN-BIOTECH-INC, PHARMAKON-ADVISORS-LP and 6 more. View the full supplier network at chainsifter.com/chain/GERN.

Who are Geron Corporation's major customers?

Geron Corporation (GERN) key customers include: Lineage Cell Therapeutics, Inc., Lineage Cell Therapeutics, Inc., ASTERIAS-BIOTHERAPEUTICS-INC. View the full customer network at chainsifter.com/chain/GERN.

What sector is Geron Corporation in?

Geron Corporation (GERN) operates in the general sector. ChainSifter tracks its verified supply chain relationships including suppliers, customers, and strategic partners.

Geron Corporation Suppliers, Customers & Supply Chain (GERN)

11Suppliers

3Customers

3Debt Items

20Related Chains

Source-Backed Evidence Depth

Geron Corporation (GERN) is shown with relationship data already present in ChainSifter's database. Counts below come from stored supply-chain records and filing/source URLs where available; missing source URLs are not filled in or estimated.

18Total relationships

3Distinct source URLs

9High confidence

0.810Average confidence

2026-10-28Latest database update

ChainSifter does not infer unreported suppliers, customers, ownership, acquisitions, debt exposure, revenue dependency, or future supply-chain events on this public page.

Geron Corporation Suppliers

Ticker	Name	Confidence	Evidence
BIOPHARMA-CREDIT-INVESTMENTS-V-MASTER-LP	BIOPHARMA-CREDIT-INVESTMENTS-V-MASTER-LP	92%	On January 5, 2026, Geron Corporation entered into that certain first amendment to loan agreement with BioPharma Credit Investments V (Master) LP and BPCR Limited Partnership (each, a 'Lender'), whic…
BIOPHARMA-CREDIT-PLC	BIOPHARMA-CREDIT-PLC	92%	On January 5, 2026, Geron Corporation entered into that certain first amendment to loan agreement with BioPharma Credit Investments V (Master) LP and BPCR Limited Partnership (each, a 'Lender'), whic…
BPCR-LIMITED-PARTNERSHIP	BPCR-LIMITED-PARTNERSHIP	92%	On January 5, 2026, Geron Corporation entered into that certain first amendment to loan agreement with BioPharma Credit Investments V (Master) LP and BPCR Limited Partnership (each, a 'Lender'), whic…
JANSSEN-BIOTECH-INC	JANSSEN-BIOTECH-INC	92%	Upon the effective date of termination of the license and collaboration agreement, or the Prior Collaboration Agreement, with Janssen Biotech, Inc., or Janssen, on September 28, 2018, we regained glo…
PHARMAKON-ADVISORS-LP	PHARMAKON-ADVISORS-LP	92%	On January 5, 2026, Geron Corporation entered into that certain first amendment to loan agreement with BioPharma Credit Investments V (Master) LP and BPCR Limited Partnership (each, a 'Lender'), whic…
JSPR	Jasper Therapeutics, Inc.	72%	Reciprocal relationship from JSPR graph: Reciprocal relationship from GERN graph: Reciprocal relationship from JSPR graph: Reciprocal relationship from GERN graph: Reciprocal relationship from JSPR g…
KROS	Keros Therapeutics, Inc.	72%	Reciprocal relationship from KROS graph: Reciprocal relationship from GERN graph: rrent and potential commercial uses and current and potential future clinical trials. We do not have direct control o…
LCTX	Lineage Cell Therapeutics, Inc.	72%	Reciprocal relationship from LCTX graph: Reciprocal relationship from GERN graph: Reciprocal relationship from LCTX graph: Reciprocal relationship from GERN graph: Reciprocal relationship from LCTX g…
LIXT	Lixte Biotechnology Holdings, Inc.	72%	Reciprocal relationship from LIXT graph: Reciprocal relationship from GERN graph: rrent and potential commercial uses and current and potential future clinical trials. We do not have direct control o…
NVSEF	Novartis AG	72%	Reciprocal relationship from NVSEF graph: Reciprocal relationship from GERN graph: Reciprocal relationship from NVSEF graph: Reciprocal relationship from GERN graph: Reciprocal relationship from NVSE…
RIGL	Rigel Pharmaceuticals, Inc.	72%	Reciprocal relationship from RIGL graph: Reciprocal relationship from GERN graph: Reciprocal relationship from RIGL graph: Reciprocal relationship from GERN graph: Reciprocal relationship from RIGL g…

Geron Corporation Customers

Ticker	Name	Confidence	Evidence
LCTX	Lineage Cell Therapeutics, Inc.	72%	Reciprocal relationship from LCTX graph: Reciprocal relationship from GERN graph: Reciprocal relationship from LCTX graph: Reciprocal relationship from GERN graph: ctual property and proprietary tech…
LCTX	Lineage Cell Therapeutics, Inc.	72%	ctual property and proprietary technology, to Lineage Cell Therapeutics, Inc. (formerly BioTime, Inc. which acquired Asterias Biotherapeutics, Inc.) in 2013, we are entitled to receive royalties on s…
ASTERIAS-BIOTHERAPEUTICS-INC	ASTERIAS-BIOTHERAPEUTICS-INC	62%	ctual property and proprietary technology, to Lineage Cell Therapeutics, Inc. (formerly BioTime, Inc. which acquired Asterias Biotherapeutics, Inc.) in 2013, we are entitled to receive royalties on s…

Geron Corporation Debt Obligations

Instrument	Description	Confidence	Evidence
GERN-DEBT-9765	Xbrl Convertible	90%	xbrl convertible detail from xbrl 2015-12-31.
GERN-DEBT-9764	Warrants outstanding: 1619275	90%	xbrl warrant detail from xbrl 2025-12-31.
GERN-DEBT	Debt stack $120.1M	90%	Market cache reports total debt of $120.1M.

Geron Corporation Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for Geron Corporation.

Geron Corporation Ownership

Holder	Name	Confidence	Evidence
GERN-OWNER-RA-CAPITAL-MANAGEMENT-L-P	RA CAPITAL MANAGEMENT, L.P.	90%	13F overlay lists RA CAPITAL MANAGEMENT, L.P. as top holder; 256 tracked holders.

Geron Corporation Extended Supply Chain Network

Ticker	Name	Chain Index	Hops	Relationship Types
RIGL	Rigel Pharmaceuticals, Inc.	100.00	1	['supplier']
KROS	Keros Therapeutics, Inc.	100.00	1	['supplier']
LIXT	Lixte Biotechnology Holdings, Inc.	100.00	1	['supplier']
JSPR	Jasper Therapeutics, Inc.	100.00	1	['supplier']
LCTX	Lineage Cell Therapeutics, Inc.	100.00	1	['customer', 'supplier']
NVSEF	Novartis AG	100.00	1	['supplier']
CYTK	Cytokinetics, Incorporated	50.00	2
BIOA	BioAge Labs, Inc.	50.00	2
ANL	Adlai Nortye Ltd.	50.00	2
HCM	HUTCHMED (China) Limited	50.00	2
EWTX	Edgewise Therapeutics, Inc.	50.00	2
NVO	Novo Nordisk A/S	50.00	2
CTMX	CytomX Therapeutics, Inc.	50.00	2
RGNX	REGENXBIO Inc.	50.00	2
CLDX	Celldex Therapeutics, Inc.	50.00	2
BNBX	BNB Plus Corp.	50.00	2
ALNY	Alnylam Pharmaceuticals, Inc.	50.00	2
ORANY	ORANGE	50.00	2
SDGR	Schrödinger, Inc.	50.00	2
ERAS	Erasca, Inc.	50.00	2

Geron Corporation Supply Chain